Loading...
Long Acting Injectable Therapies Will Drive Margin Expansion And Support Long Term Recovery Solutions
n/a
n/a
AnalystConsensusTarget's Fair Value
n/a
1Y
208.0%7D
-0.7%1Y
208.0%7D
-0.7%You can edit this narrative until Dec 19 10:05 AM. Then, changes will post as Updates.